THE PREVALENCE OF MULTI-DRUG RESISTANT TUBERCULOSIS (MDR TB) AND ANTI-TUBERCULOSIS THERAPY AMONG PATIENTS WITH HIV-RELATED TUBERCULOSIS AND THOSE WITH NON HIV-RELATED TUBERCULOSIS

Citation:
KANGANGI DRGIKUNJUJ. "THE PREVALENCE OF MULTI-DRUG RESISTANT TUBERCULOSIS (MDR TB) AND ANTI-TUBERCULOSIS THERAPY AMONG PATIENTS WITH HIV-RELATED TUBERCULOSIS AND THOSE WITH NON HIV-RELATED TUBERCULOSIS.". In: journal. Douglas McLean Publishing; 1992.

Abstract:

In treatment of tuberculosis infection it is important for cure to be obtained. Tuberculosis is a bacterial infection thus there is risk of drug resistance. If a dose of anti-tuberculosis is drug is missed, full cure cannot be obtained and reactivation of infection can occur at a later stage. Furthermore, multi-drug resistance which is also common to many bacterial infections may develop as a result of missing the prescribed doses of drug as is required in rational use of antibiotic drugs. The patients infected with HIV/AIDS can live for a long time if they treat opportunistic infection. These patients have a high risk of contacting tuberculosis. The study will use measures set up by the Ministry of Health to control tuberculosis and HIV/AIDS pandemic such as Direct Observed therapy (DOT).DOT has been adopted by the ministry of Health Tuberculosis control programme. Follow up will done by evaluating sputum smears, culture and drug susceptibility test, and examining chest radiographs. Therefore the follow-up to determine multi-drug resistant tuberculosis needs a specialized Microbiology laboratory that is equipped with necessary facilities. The study mainly carried out survey to see the effectiveness of DOT in completion of therapy and in combating the problem of drug resistance which may arise especially from high risk groups such as those infected with HIV/AIDS. The problem of poor drug compliance and drug toxicity was also considered in assessing drug therapy.   

Notes:

n/a

Website

UoN Websites Search